Cow Milk Infant Formula Market To Surpass USD 46.6 Bn by 2034

Overview

New York, NY – June 12, 2025 – The Global Cow Milk Infant Formula Market is experiencing steady growth, driven by rising demand for convenient and nutritious feeding options for infants. Valued at USD 32.7 billion in 2024, the market is projected to reach USD 46.6 billion by 2034, growing at a CAGR of 3.6% from 2025 to 2034.

In 2024, the Wet Process Type led the global Cow Milk Infant Formula market, securing a 48.4% share. Its dominance is driven by superior nutrient retention and a consistent final product. Regular Infant Formula dominated in 2024, capturing a 56.9% share of the global Cow Milk Infant Formula market. Infant Formula held a leading 51.3% share in the global Cow Milk Infant Formula market. This segment’s prominence reflects the rising demand for dependable nutrition for infants who are partially or fully not breastfed.

Key Takeaways

• Cow Milk Infant Formula Market size is expected to be worth around USD 46.6 billion by 2034, from USD 32.7 billion in 2024, growing at a CAGR of 3.6%.
• Wet Process Type held a dominant market position, capturing more than a 48.4% share.
• Regular Infant Formula held a dominant market position, capturing more than a 56.9% share.
• Infant Formula held a dominant market position, capturing more than a 51.3% share.
• Offline held a dominant market position, capturing more than a 56.1% share of the global Cow Milk Infant Formula market.
• North America emerged as the leading region in the Cow Milk Infant Formula market, commanding a substantial 45.8% share, which translates to a market value of approximately USD 14.9 billion.

How Growth is Impacting the Economy

• The Cow Milk Infant Formula Market’s robust growth significantly impacts the global economy. As the market expands, it creates jobs across the manufacturing, distribution, and retail sectors, boosting employment rates. Increased demand drives investments in dairy farming and processing, benefiting agricultural economies, particularly in countries like the U.S. and New Zealand. The rise in organic and premium formulas spurs innovation, attracting R&D investments and fostering technological advancements in food processing.
• This growth also enhances export revenues, with major players like Nestlé and Danone strengthening trade networks. However, supply chain disruptions, such as those from global health crises, can challenge market stability, affecting prices and availability. Rising consumer spending on high-quality infant nutrition supports economic activity in emerging markets like India and China, where urbanization fuels demand. Overall, the market’s growth stimulates economic diversification and resilience, though it requires careful management of regulatory and safety concerns.

➤ Curious about the content? Explore a sample copy of this report – https://market.us/report/global-cow-milk-infant-formula-market/request-sample/

Strategies for Businesses

• Businesses in the cow’s milk infant formula market should focus on innovation, developing organic and plant-based formulas to meet the rising demands of health-conscious consumers. Strengthening supply chains through local sourcing and robust logistics can mitigate disruptions. Investing in R&D to enhance nutritional profiles, like adding probiotics or human milk oligosaccharides, will differentiate products.
• Targeting emerging markets, such as the Asia-Pacific region, with tailored marketing and affordable pricing can capture growing demand from the middle class. Compliance with strict regulations and transparent labeling builds consumer trust. Strategic partnerships with retailers and e-commerce platforms will expand market reach, ensuring competitiveness in a dynamic, safety-sensitive industry.

Report Scope

➤ Directly purchase a copy of the report – https://market.us/purchase-report/?report_id=149131

Key Market Segments

By Type

• In 2024, the Wet Process Type led the global Cow Milk Infant Formula market, securing a 48.4% share. Its dominance is driven by superior nutrient retention and a consistent final product. The wet process enables thorough ingredient blending before drying, enhancing digestibility and nutritional quality. This method is widely adopted in advanced dairy regions like Europe, China, and the U.S., where efficient processing and high-quality standards are prioritized.

By Product

• Regular Infant Formula dominated in 2024, capturing a 56.9% share of the global Cow Milk Infant Formula market. As the standard choice for healthy, full-term infants, it provides a balanced mix of proteins, carbohydrates, and vitamins, closely mimicking breast milk. Its affordability and widespread availability across online and offline retail channels make it the preferred option for many households.

By Application

• In 2024, Infant Formula held a leading 51.3% share in the global Cow Milk Infant Formula market. This segment’s prominence reflects the rising demand for dependable nutrition for infants who are partially or fully not breastfed. Cow milk-based formulas, designed to be gentle on delicate digestive systems, offer essential nutrients during critical early development, making them a trusted choice for families worldwide.

Regional Analysis

• North America leads the global Cow Milk Infant Formula market, capturing a 45.8% share, equivalent to roughly USD 14.9 billion. The United States drives this dominance, with many working mothers choosing infant formula for its convenience and reliable nutrition. Growing awareness of infant health, paired with demand for high-quality, nutrient-enriched formulas, fuels market expansion in the region. The region’s strong retail network, including supermarkets, pharmacies, and e-commerce platforms, ensures widespread product availability.
• Effective marketing and strong brand loyalty further solidify North America’s market leadership. Looking ahead, the North American Cow Milk Infant Formula market is set for steady growth, propelled by product innovation, heightened health awareness, and sustained demand for practical nutrition solutions. However, manufacturers must address challenges like regulatory oversight and transparency to maintain consumer confidence and market share.

Recent Developments

1. Abbott

• Abbott has relaunched its Similac infant formula in the US recall due to contamination concerns. The company has enhanced safety protocols and introduced new quality checks. Abbott also launched Similac 360 Total Care, a new formula with five HMO prebiotics to support immune health. The product is designed to be closer to breast milk. Abbott continues to focus on innovation in infant nutrition.

2. Arla

• Arla Foods Ingredients has introduced Lacprodan Premium, a high-quality whey protein concentrate for infant formula, designed to mimic breast milk’s nutritional profile. The company emphasizes sustainable sourcing and clean-label ingredients. Arla also partners with Chinese manufacturers to expand its infant nutrition portfolio in Asia.

3. Beingmate

• Beingmate launched a new infant formula series, Bei Yin Mei, featuring A2 β-casein milk protein, which is easier to digest. The company is expanding in Southeast Asia and investing in R&D for formulas with probiotics and HMOs. Beingmate also strengthened its supply chain to ensure safety.

4. Danone

• Danone introduced Aptamil Supreme+, an advanced infant formula with a unique blend of HMOs, probiotics, and prebiotics for gut health. The company also committed to reducing carbon emissions in its formula production. Danone expanded its presence in China with locally produced formulas.

5. Heilongjiang Feihe Dairy Co., Ltd

• Feihe launched Star Flying Fan, an organic infant formula with added lactoferrin and probiotics. The company focuses on premiumization and has expanded exports to the Middle East. Feihe also invested in a new production facility to boost capacity.

Conclusion

The Cow Milk Infant Formula Market is growing, driven by rising demand for high-quality, nutritious products that mimic breast milk. Leading companies like Abbott, Danone, and Feihe are innovating with added HMOs, probiotics, and A2 milk proteins to improve digestion and immunity. Safety remains a top priority after past recalls, pushing brands to strengthen quality control. Emerging markets, especially in Asia and the Middle East, are key growth areas, with local and international players expanding production. 

Discuss Your Needs With Our Analyst

Please share your requirements with more details so our analyst can check if they can solve your problem(s)

Request a Sample Download PDF